REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma

Journal of Surgical Oncology

Volumn 105, Issue 2, 2012, Pages 189-194

  Moon, Jeong Ho ^a   Fujiwara, Yoshiyuki ^a   Nakamura, Yurika ^a   Okada, Kaoru ^a   Hanada, Hiroyuki ^a   Sakakura, Chohei ^b   Takiguchi, Shuji ^a   Nakajima, Kiyokazu ^a   Miyata, Hiroshi ^a   Yamasaki, Makoto ^a   Kurokawa, Yukinori ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

gastric cancer; molecular diagnosis; peritoneal dissemination; REGIV; TRC

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; MESSENGER RNA; REGENERATING ISLET DERIVED FAMILY MEMBER 4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; GASTRECTOMY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE GENETICS; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LECTINS, C-TYPE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84855353428     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22021     Document Type: Article

References (23)

1. Ferlay J, Shin HR, Bray F, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
3. Dupont JB, Jr., Lee JR, Burton GR, et al.: Adenocarcinoma of the stomach: Review of 1,497 cases. Cancer 1978; 41: 941-947. (Pubitemid 8313231)
4. Yamada E, Miyaishi S, Nakazato H, et al.: The surgical treatment of cancer of the stomach. Int Surg 1980; 65: 387-399. (Pubitemid 12115232)
5. Yoo CH, Noh SH, Shin DW, et al.: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87: 236-242. (Pubitemid 30088655)
6. Hartupee JC, Zhang H, Bonaldo MF, et al.: Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 2001; 1518: 287-293. (Pubitemid 32324196)
7. Oue N, Mitani Y, Aung PP, et al.: Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005; 207: 185-198. (Pubitemid 41404149)
8. Gu Z, Rubin MA, Yang Y, et al.: Reg IV: A promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res 2005; 11: 2237-2243. (Pubitemid 40490182)
9. Violette S, Festor E, Pandrea-Vasile I, et al.: Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 2003; 103: 185-193. (Pubitemid 35461510)
10. Takehara A, Eguchi H, Ohigashi H, et al.: Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci 2006; 97: 1191-1197. (Pubitemid 44430644)
11. Tamura H, Ohtsuka M, Washiro M, et al.: Reg IV expression and clinicopathologic features of gallbladder carcinoma. Hum Pathol 2009; 40: 1686-1692.
12. Zhang Y, Lai M, Lv B, et al.: Overexpression of Reg IV in colorectal adenoma. Cancer Lett 2003; 200: 69-76. (Pubitemid 37222360)
13. Guo Y, Xu J, Li N, et al.: RegIV potentiates colorectal carcinoma cell migration and invasion via its CRD domain. Cancer Genet Cytogenet 2010; 199: 38-44.
14. Bishnupuri KS, Luo Q, Murmu N, et al.: Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 2006; 130: 137-149. (Pubitemid 43049844)
15. Mitani Y, Oue N, Matsumura S, et al.: Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 2007; 26: 4383-4393. (Pubitemid 47014457)
16. Kuniyasu H, Oue N, Sasahira T, et al.: Reg IV enhances peritoneal metastasis in gastric carcinomas. Cell Prolif 2009; 42: 110-121.
17. Koizumi W, Narahara H, Hara T, et al.: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. Lancet Oncol 2008; 9: 215-221.
18. Japanese Gastric Cancer A: Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998; 1: 10-24.
19. Therasse P, Arbuck SG, Eisenhauer EA, et al.: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
20. Ishiguro T, Saitoh J, Horie R, et al.: Intercalation activating fluorescence DNA probe and its application to homogeneous quantification of a target sequence by isothermal sequence amplification in a closed vessel. Anal Biochem 2003; 314: 77-86. (Pubitemid 36299022)
21. Yamagishi H, Fukui H, Sekikawa A, et al.: Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: Comparison with mucin phenotype and prognostic markers. Mod Pathol 2009; 22: 906-913.
22. Miyagawa K, Sakakura C, Nakashima S, et al.: Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis. Anticancer Res 2008; 28: 1169-1179. (Pubitemid 351578855)
23. Ishii T, Fujiwara Y, Ohnaka S, et al.: Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis. Ann Surg Oncol 2004; 11: 778-785. (Pubitemid 40486693)